Featured Research

from universities, journals, and other organizations

Key gene found in childhood cancer

Date:
May 5, 2011
Source:
Albert Einstein College of Medicine
Summary:
Scientists have identified the Aurora A gene -- which is vital for tumor growth and known to be expressed at higher-than-normal levels in many cancers -- as a target for potential therapies for rhabdoid tumors, aggressive childhood cancers that usually strike children under three years old and affect the brain or kidneys. The disease is extremely rare and is particularly difficult to treat and almost always fatal.

There are no effective treatments for rhabdoid tumors -- aggressive childhood cancers that usually strike children under three years old and affect the brain or kidneys. The disease is extremely rare -- fewer than 10 cases are diagnosed each year in the U.S. -- but is particularly difficult to treat and almost always fatal.

Now scientists at Albert Einstein College of Medicine of Yeshiva University have identified a target for potential therapies for these tumors: a gene called Aurora A that is vital for tumor growth. The research team was led by Ganjam Kalpana, Ph.D., professor of genetics and of microbiology & immunology, the Mark Trauner Faculty Scholar in Neuro-oncology at Einstein. Their findings appear in the April 26 online issue of Cancer Research.

The Aurora A gene is known to be expressed at higher-than-normal levels in many cancers, and its expression is associated with poor prognosis. Scientists have also known that mutations in a tumor suppressor gene called INI1/hSNF5 can lead to rhabdoid tumors. In this study, the Kalpana team found that, in rhabdoid tumors, loss of the tumor suppressor gene INI1/hSNF5 leads to changes in Aurora A's expression that are crucial for tumor growth.

In experiments involving rhabdoid tumors and tumor cell lines, the Einstein scientists showed for the first time that Aurora A is highly expressed in both human and mouse rhabdoid tumors, that the loss of the INI1/hSNF5 tumor suppressor gene from rhabdoid tumor cells leads to the "de-repression" of Aurora A, and that knocking down Aurora A's expression in rhabdoid tumor cells potently inhibits the growth of those cells.

"Our findings indicate that targeting Aurora A could be an effective strategy for halting rhabdoid tumor growth," said Dr. Kalpana. She notes that many Aurora A inhibitors are now being tested against several types of cancers, includingmelanoma and non-Hodgkin's lymphoma, and other researchers have now expressed interest in using Aurora A inhibitors in trials for children with rhabdoid brain tumors.

Seung Jae Lee, Ph.D., a postdoctoral fellow in the Kalpana laboratory, is the first author of the paper and played a major role in the study. He was helped by Velasco Cimica, Ph.D., and Nandini Ramachandra, M.S., both at Einstein. David Zagzag, M.D., at New York University provided clinical samples and performed immunohistochemistry. The paper is titled "Aurora A is a Repressed Effector Target of the Chromatin Remodeling Protein INI1/hSNF5 Required for Rhabdoid Tumor Cell Survival." The research was funded with grants from the American Cancer Society, Children's Tumor Foundation, the Department of Defense, Albert Einstein Cancer Center, and the Feinberg Foundation.


Story Source:

The above story is based on materials provided by Albert Einstein College of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Lee, V. Cimica, N. Ramachandra, D. Zagzag, G. V. Kalpana. Aurora A Is a Repressed Effector Target of the Chromatin Remodeling Protein INI1/hSNF5 Required for Rhabdoid Tumor Cell Survival. Cancer Research, 2011; 71 (9): 3225 DOI: 10.1158/0008-5472.CAN-10-2167

Cite This Page:

Albert Einstein College of Medicine. "Key gene found in childhood cancer." ScienceDaily. ScienceDaily, 5 May 2011. <www.sciencedaily.com/releases/2011/05/110505124041.htm>.
Albert Einstein College of Medicine. (2011, May 5). Key gene found in childhood cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/05/110505124041.htm
Albert Einstein College of Medicine. "Key gene found in childhood cancer." ScienceDaily. www.sciencedaily.com/releases/2011/05/110505124041.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins